Pine Bridge Investments, L.P. Zai Lab LTD Transaction History

Pine Bridge Investments, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$23.14 - $49.68 $5,599 - $12,022	242 Added 242.0%	342 $12,000
Q1 2022 May 12, 2022	SELL	$27.77 - $64.4 $2,777 - $6,440	-100 Reduced 50.0%	100 $4,000
Q4 2021 Feb 10, 2022	BUY	$54.9 - $105.21 $10,980 - $21,042	200 New	200 $13,000
Q4 2017 Feb 09, 2018	SELL	$21.23 - $34.09 $743,050 - $1.19 Million	-35,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$27.0 - $31.11 $945,000 - $1.09 Million	35,000	35,000 $945,000

133

48.9M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.74B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.